ARTICLE | Company News
Lansen Pharmaceutical, Novartis deal
April 7, 2014 7:00 AM UTC
Lansen acquired Chinese rights to the Sicorten Plus brand from Novartis for $8 million up front. Lansen said it also acquired the Swiss Marketing Authorization, know-how, books and records, specified...